Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
, and Hans Wolf 1 Department of Medical Biochemistry and Danish Centre for Human Genome Research, The University of Aarhus, Aarhus, Denmark 2 Department of Urology, Skejby Hospital, Aarhus, Denmark...Beverage protect against bladder cancer
According to a study in the Community Health, coffee may protect against the development of bladder cancer, especially in smokers..Researchers analysed data from all new and already diagnosed cases of bladder cancer over a 1 year period from 10 general hospitals.// All patients and over 500 cases supplied details of their employment history, tobacco use, including exposure to environmental tobacc...Chemotherapy Effective for Bladder Cancer
A combination treatment helps patients with bladder cancer live longer, according to a new study. The research shows patients who receive chemotherapy plus surgery //survive longer than patients who only have surgery. Doctors call this an important advance in the treatment of this deadly disease. Bladder cancer is the fourth most common cancer in men and the eighth most common cancer i...More Causes of Bladder Cancer Identified
Smoking is a well known risk factor for bladder cancer but researchers now say they have uncovered even more factors // that could lead to the disease. For the study researchers studied 298 patients with bladder cancer and 308 people who served as controls. The participants were surveyed about their smoking habits and their exposure to other environmental factors believed to be related t...NMP22® BladderChek® Kit (24-test kit)
Description:The NMP22® Test Kit is a quantitative microplate enzyme immunoassay that can identify bladder cancer patients who are at risk for rapid recurrence or occult disease. The test is performed on a single voided urine sample and is twice as sensitive as urine cytology. Urologists can use NMP22 values to improve patient outcome by identifying those patients who may benefit from more or less aggress...NMP22® BladderChek® Kit (1-test kit)
Description:The NMP22® Test Kit is a quantitative microplate enzyme immunoassay that can identify bladder cancer patients who are at risk for rapid recurrence or occult disease. The test is performed on a single voided urine sample and is twice as sensitive as urine cytology. Urologists can use NMP22 values to improve patient outcome by identifying those patients who may benefit from more or less aggress...Vysis UroVysion Bladder Cancer Kit
Description:The UroVysion Bladder Cancer Kit (UroVysion Kit) is designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. Results from the UroVysion Kit are intended for use, in conjunction with and not in lieu of current standard diagnostic procedures, as...